Gene · 634
Papers3,222
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,222
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
The Determination of Polycyclic Aromatic Hydrocarbons (PAHs) with HPLC-DAD-FLD and GC-MS Techniques in the Dissolved and Particulate Phase of Road-Tunnel Wash Water: A Case Study for Cross-Array Comparisons and Applications. | Toxics | 2022 | 35878304 | PubTator, text mining | PubMed |
| Immune Evasion of Hepatoma Cancer Stem-Like Cells from Natural Killer Cells. | Ann Surg Oncol | 2022 | 35876924 | PubTator, text mining | PubMed |
| LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma. | Front Public Health | 2022 | 35874989 | PubTator, text mining | PubMed |
| Editorial: The Potential Effects and Mechanisms of Traditional Chinese Medicine on Bone Homeostasis and Remodeling. | Front Endocrinol (Lausanne) | 2022 | 35873007 | PubTator, text mining | PubMed |
| Identifying miRNAs Associated with the Progression of Keloid through mRNA-miRNA Network Analysis and Validating the Targets of miR-29a-3p in Keloid Fibroblasts. | Biomed Res Int | 2022 | 35872873 | PubTator, text mining | PubMed |
| Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. | NPJ Breast Cancer | 2022 | 35869114 | PubTator, text mining | PubMed |
| Validation of Messenger Ribonucleic Acid Markers Differentiating Among Human Acute Respiratory Distress Syndrome Subgroups in an Ovine Model of Acute Respiratory Distress Syndrome Phenotypes. | Front Med (Lausanne) | 2022 | 35865167 | PubTator, text mining | PubMed |
| Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. | Front Oncol | 2022 | 35860590 | PubTator, text mining | PubMed |
| i-Modern: Integrated multi-omics network model identifies potential therapeutic targets in glioma by deep learning with interpretability. | Comput Struct Biotechnol J | 2022 | 35860408 | PubTator, text mining | PubMed |
| Animal Models and Pathogenesis of Ulcerative Colitis. | Comput Math Methods Med | 2022 | 35860188 | PubTator, text mining | PubMed |
| Nuclear-localized, iron-bound superoxide dismutase-2 antagonizes epithelial lineage programs to promote stemness of breast cancer cells via a histone demethylase activity. | Proc Natl Acad Sci U S A | 2022 | 35858297 | PubTator, text mining | PubMed |
| A dual hesitant q-rung orthopair enhanced MARCOS methodology under uncertainty to determine a used PPE kit disposal. | Environ Sci Pollut Res Int | 2022 | 35857161 | PubTator, text mining | PubMed |
| Colorectal Cancer Chemotherapy Drug Bevacizumab May Induce Muscle Atrophy Through CDKN1A and TIMP4. | Front Oncol | 2022 | 35847900 | PubTator, text mining | PubMed |
| Mortality Prediction in Sepsis With an Immune-Related Transcriptomics Signature: A Multi-Cohort Analysis. | Front Med (Lausanne) | 2022 | 35847809 | PubTator, text mining | PubMed |
| Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression. | Oncoimmunology | 2022 | 35845722 | PubTator, text mining | PubMed |
| Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science. | Gut | 2022 | 35820782 | PubTator, text mining | PubMed |
| Knocking Out of CEACAM1 Can Reduce Oxidative Stress and Promote Cell Proliferation in the HPMVECs under Hypoxia. | J Immunol Res | 2022 | 35812245 | PubTator, text mining | PubMed |
| The Role of CMV Infection in Primary Lesions, Development and Clinical Expression of Atherosclerosis. | J Clin Med | 2022 | 35807114 | PubTator, text mining | PubMed |
| What Inhibits Natural Killers' Performance in Tumour. | Int J Mol Sci | 2022 | 35806034 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. | Int J Mol Sci | 2022 | 35805965 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/634/papers?page=36